Literature DB >> 24816791

The process from symptom onset to rheumatology clinic in polymyalgia rheumatica.

Ediz Dalkılıç1, Ayşe Nur Tufan, Emre Hafızoğlu, Merve Hafızoğlu, Fatih Tufan, Ferhat Oksuz, Yavuz Pehlivan, Mustafa Yurtkuran.   

Abstract

Polymyalgia rheumatica (PMR) is an inflammatory disease of individuals aged over 50 years. Because of the concomitant malignancy possibility and the high prevalence of constitutional symptoms seen in this condition, patients with classical clinical picture often experience delay in diagnosis and treatment and are exposed to a wide list of laboratory and imaging procedures. In this study, we aimed to explore the adventure these patients experience from symptom onset to rheumatology clinic. A total of 106 PMR patients (84 women, 22 men) mean age 70.1 ± 8 were analyzed retrospectively. The time period from the onset of symptoms and referral to rheumatology specialists was explored. Diagnostic methods applied to these patients, antibiotic use and hospitalization during this period were recorded. The interval between the onset of the symptoms and admission to rheumatology unit was 13 ± 13 months. In this period, abdominal computed tomography (29.2 %), chest computed tomography (21.7 %), cranial magnetic resonance imaging (18.9 %) and whole-body scintigraphy (3.8 %) were applied to the patients. About 30 % of the patients were hospitalized for a mean period of 7 ± 3 days before referral to rheumatology unit, and 30 % of the patients were given antibiotics. In order to reduce the delay in the diagnosis of PMR and prevent unnecessary and expensive diagnostic methods, education of clinicians about the diagnosis of PMR may be beneficial.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24816791     DOI: 10.1007/s00296-014-3034-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  Length of sedimentation reaction in undiluted blood (erythrocyte sedimentation rate): variations with sex and age and reference limits.

Authors:  E Piva; M C Sanzari; G Servidio; M Plebani
Journal:  Clin Chem Lab Med       Date:  2001-05       Impact factor: 3.694

2.  Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study.

Authors:  C Salvarani; G G Hunder
Journal:  Arthritis Rheum       Date:  2001-04

3.  The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.

Authors:  M A Gonzalez-Gay; C Garcia-Porrua; C Salvarani; I Olivieri; G G Hunder
Journal:  J Rheumatol       Date:  2000-09       Impact factor: 4.666

4.  Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients.

Authors:  Miguel A Gonzalez-Gay; Sonia Barros; Maria J Lopez-Diaz; Carlos Garcia-Porrua; Amalia Sanchez-Andrade; Javier Llorca
Journal:  Medicine (Baltimore)       Date:  2005-09       Impact factor: 1.889

5.  Polymyalgia rheumatica and the American Rheumatism Association criteria for rheumatoid arthritis.

Authors:  L A Healey
Journal:  Arthritis Rheum       Date:  1983-12

6.  A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.

Authors:  G Myklebust; J T Gran
Journal:  Br J Rheumatol       Date:  1996-11

7.  Cancer in association with polymyalgia rheumatica and temporal arteritis.

Authors:  H J Haga; G E Eide; J Brun; A Johansen; F Langmark
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

Review 8.  Polymyalgia rheumatica and giant-cell arteritis.

Authors:  Carlo Salvarani; Fabrizio Cantini; Gene G Hunder
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

9.  [Erythrocyte sedimentation rate in a population of 47,205 adults. Variation with age].

Authors:  Y Tsouderos; J Chrétien; A Ryckewaert
Journal:  Rev Rhum Mal Osteoartic       Date:  1982 Jul-Sep

10.  An evaluation of criteria for polymyalgia rheumatica.

Authors:  H A Bird; W Esselinckx; A S Dixon; A G Mowat; P H Wood
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103

View more
  5 in total

Review 1.  Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient.

Authors:  Marcin Milchert; Marek Brzosko
Journal:  Indian J Med Res       Date:  2017-05       Impact factor: 2.375

2.  Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. The Italian Case.

Authors:  Ciro Manzo
Journal:  Med Sci (Basel)       Date:  2019-08-30

Review 3.  Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature.

Authors:  Elvis Hysa; Ali Ghorbannia; Amir Emamifar; Marcin Milchert; Ciro Manzo
Journal:  Reumatologia       Date:  2021-11-07

4.  Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries.

Authors:  Ciro Manzo; Marcin Milchert; Carlo Venditti; Alberto Castagna; Arvind Nune; Maria Natale; Marek Brzosko
Journal:  Life (Basel)       Date:  2022-06-30

5.  Diagnosis of polymyalgia rheumatica in primary health care: favoring and confounding factors - a cohort study.

Authors:  Ciro Manzo; Maria Natale; Enea Traini
Journal:  Reumatologia       Date:  2018-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.